|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM288964179 |
003 |
DE-627 |
005 |
20231225061516.0 |
007 |
cr uuu---uuuuu |
008 |
231225s2019 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1002/adma.201801159
|2 doi
|
028 |
5 |
2 |
|a pubmed24n0963.xml
|
035 |
|
|
|a (DE-627)NLM288964179
|
035 |
|
|
|a (NLM)30260511
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Xia, Yufei
|e verfasserin
|4 aut
|
245 |
1 |
4 |
|a The Horizon of the Emulsion Particulate Strategy
|b Engineering Hollow Particles for Biomedical Applications
|
264 |
|
1 |
|c 2019
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 05.02.2020
|
500 |
|
|
|a Date Revised 30.09.2020
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a © 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
|
520 |
|
|
|a With their hierarchical structures and the substantial surface areas, hollow particles have gained immense research interest in biomedical applications. For scalable fabrications, emulsion-based approaches have emerged as facile and versatile strategies. Here, the recent achievements in this field are unfolded via an "emulsion particulate strategy," which addresses the inherent relationship between the process control and the bioactive structures. As such, the interior architectures are manipulated by harnessing the intermediate state during the emulsion revolution (intrinsic strategy), whereas the external structures are dictated by tailoring the building blocks and solidification procedures of the Pickering emulsion (extrinsic strategy). Through integration of the intrinsic and extrinsic emulsion particulate strategy, multifunctional hollow particles demonstrate marked momentum for label-free multiplex detections, stimuli-responsive therapies, and stem cell therapies
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Review
|
650 |
|
4 |
|a Pickering emulsions
|
650 |
|
4 |
|a label-free detections
|
650 |
|
4 |
|a multiple emulsions
|
650 |
|
4 |
|a stem-cell tissue regeneration
|
650 |
|
4 |
|a stimuli-responsive drug delivery
|
650 |
|
7 |
|a Biocompatible Materials
|2 NLM
|
650 |
|
7 |
|a Emulsions
|2 NLM
|
700 |
1 |
|
|a Na, Xiangming
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Wu, Jie
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Ma, Guanghui
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Advanced materials (Deerfield Beach, Fla.)
|d 1998
|g 31(2019), 38 vom: 27. Sept., Seite e1801159
|w (DE-627)NLM098206397
|x 1521-4095
|7 nnns
|
773 |
1 |
8 |
|g volume:31
|g year:2019
|g number:38
|g day:27
|g month:09
|g pages:e1801159
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1002/adma.201801159
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 31
|j 2019
|e 38
|b 27
|c 09
|h e1801159
|